NCPA Seeks FTC Investigation Of CVS Caremark, With Merck-Medco As Model
Executive Summary
Independent pharmacies are hoping the Federal Trade Commission's post-merger investigation of Merck's acquisition of Medco can serve as a model for their requested investigation into the merger between CVS and Caremark
You may also be interested in...
FTC Review Of Express Scripts/Medco Merger Is First Integration Challenge
The proposed merger of two of the three major pharmacy benefit managers may have tough time clearing FTC; the agency has rejected other deals that would have left only two dominant players in a sector.
CVS Caremark’s Part D Plan Acquisition Includes NCPA Partnership, For Now
The Universal American Medicare Part D plans that CVS Caremark is aiming to acquire have operated through a long-standing partnership with the National Community Pharmacists Association, which would seem an awkward fit for the large drug chain.
CVS Caremark’s Part D Plan Acquisition Includes NCPA Partnership, For Now
The Universal American Medicare Part D plans that CVS Caremark is aiming to acquire have operated through a long-standing partnership with the National Community Pharmacists Association, which would seem an awkward fit for the large drug chain.